Maxillary Sinus Floor Infiltration: Results From a Series of 118 Maxillary Sinus Cancers.
Sinus cancer
craniomaxillofacial surgery
skull base
Journal
The Laryngoscope
ISSN: 1531-4995
Titre abrégé: Laryngoscope
Pays: United States
ID NLM: 8607378
Informations de publication
Date de publication:
Jan 2022
Jan 2022
Historique:
revised:
05
06
2021
received:
21
02
2021
accepted:
09
06
2021
pubmed:
23
6
2021
medline:
15
2
2022
entrez:
22
6
2021
Statut:
ppublish
Résumé
Maxillary cancers are rare and aggressive tumors, which can spread beyond the sinus bony walls. Preoperative assessment of infiltration of maxillary sinus floor (MSF) is paramount for surgical planning, as palatomaxillary demolition significantly impacts patients' quality of life. This study investigates the challenges involved in the preoperative and intraoperative evaluation of MSF infiltration and analyzes its prognostic relevance. Retrospective case series. A retrospective review of patients treated for sinonasal malignancies at a single Institution was performed. Patients receiving surgical-based treatment with curative intent for primary maxillary sinus cancers, between January 2000 and November 2019, were included. A cohort of 118 patients was analyzed. By comparing intraoperative findings (endoscopic assessment and frozen sections) with preoperative radiological assessment, diagnostic changes with regard to MSF infiltration were found in 27.1% (32/118 cases). MSF infiltration negatively affected the prognosis in both univariate and multivariate analyses in the overall population. In the subgroup of pT1-T3 tumors, MSF infiltration was significantly associated with reduced overall (P = .012), disease-free (P = .011), and distant recurrence-free (P = .002) survival rates. Conversely, pT classification was not able to stratify patients according to prognosis, mainly because early-staged cancers (pT1-T2) with MSF infiltration showed reduced survival rates, similar to those observed in pT3 cancers. Preoperative imaging should be integrated with intraoperative findings based on endoscopic inspection and frozen sections. Future studies are required to investigate the opportunity to incorporate MSF infiltration in the TNM staging system, considering its crucial role in defining the extent of surgery and its potential as prognosticator. 4 Laryngoscope, 132:26-35, 2022.
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
26-35Informations de copyright
© 2021 The American Laryngological, Rhinological and Otological Society, Inc.
Références
Shen W, Sakamoto N, Yang L. Prognostic models and nomograms for predicting survival of patients with maxillary sinus carcinomas. Int Forum Allergy Rhinol 2017;7:741-748.
Hanna EY, Cardenas AD, DeMonte F, et al. Induction chemotherapy for advanced squamous cell carcinoma of the paranasal sinuses. Arch Otolaryngol Head Neck Surg 2011;137:78-81.
Hayashi T, Nonaka S, Bandoh N, Kobayashi Y, Imada M, Harabuchi Y. Treatment outcome of maxillary sinus squamous cell carcinoma. Cancer 2001;92:1495-1503.
Bhattacharyya N. Factors affecting survival in maxillary sinus cancer. J Oral Maxillofac Surg 2003;61:1016-1021.
Santos MR, Servato JP, Cardoso SV, et al. Squamous cell carcinoma at maxillary sinus: clinicopathologic data in a single Brazilian institution with review of literature. Int J Clin Exp Pathol 2014;7:8823-8832.
Kreppel M, Amir Manawi NN, Scheer M, et al. Prognostic quality of the Union Internationale Contre le Cancer/American Joint Committee on Cancer TNM classification, 7th edition, for cancer of the maxillary sinus. Head Neck 2015;37:400-406.
Urken ML, Roche AM, Kiplagat KJ, et al. Comprehensive approach to functional palatomaxillary reconstruction using regional and free tissue transfer: report of reconstructive and prosthodontic outcomes of 140 patients. Head Neck 2018;40:1639-1666.
Gospodarowicz MK, Brierley JD, Wittekind C. TNM Classification of Malignant Tumours. John Wiley & Sons; 2017:272.
El-Naggar AK, Chan JKC, Grandis JR, Slootweg PJ. WHO Classification of Head and Neck Tumours. International Agency for Research on Cancer; 2017:347.
Turri-Zanoni M, Battaglia P, Karligkiotis A, et al. Transnasal endoscopic partial maxillectomy: operative nuances and proposal for a comprehensive classification system based on 1378 cases. Head Neck 2017;39:754-766.
Deganello A, Ferrari M, Paderno A, et al. Endoscopic-assisted maxillectomy: operative technique and control of surgical margins. Oral Oncol 2019;93:29-38.
Castelnuovo P, Turri-Zanoni M, Battaglia P, Antognoni P, Bossi P, Locatelli D. Sinonasal malignancies of anterior skull base: histology-driven treatment strategies. Otolaryngol Clin North Am 2016;49:183-200.
Bossi P, Saba NF, Vermorken JB, et al. The role of systemic therapy in the management of sinonasal cancer: a critical review. Cancer Treat Rev 2015;41:836-843.
Licitra L, Resteghini C, Bossi P. The evolving role of systemic therapy in the primary treatment of sinonasal cancer. Adv Otorhinolaryngol 2020;84:78-86.
Castelnuovo P, Battaglia P, Turri-Zanoni M, et al. Endoscopic endonasal surgery for malignancies of the anterior cranial base. World Neurosurg 2014;82:S22-31.
Dulguerov P, Jacobsen MS, Allal AS, Lehmann W, Calcaterra T. Nasal and paranasal sinus carcinoma: are we making progress? A series of 220 patients and a systematic review. Cancer 2001;92:3012-3029.
Dubal PM, Bhojwani A, Patel TD, et al. Squamous cell carcinoma of the maxillary sinus: a population-based analysis. Laryngoscope 2016;126:399-404.
Arosio AD, Valentini M, Canevari FR, et al. Endoscopic endonasal prelacrimal approach: radiological considerations, morbidity, and outcomes. Laryngoscope 2020. https://doi.org/10.1002/lary.29330.
Ozsaran Z, Yalman D, Baltalarli B, Anacak Y, Esassolak M, Haydaroğlu A. Radiotherapy in maxillary sinus carcinomas: evaluation of 79 cases. Rhinology 2003;41:44-48.
Nishio N, Fujimoto Y, Fujii M, et al. Craniofacial resection for T4 maxillary sinus carcinoma: managing cases with involvement of the skull Base. Otolaryngol Head Neck Surg 2015;153:231-238.
Jiang GL, Ang KK, Peters LJ, Wendt CD, Oswald MJ, Goepfert H. Maxillary sinus carcinomas: natural history and results of postoperative radiotherapy. Radiother Oncol 1991;21:193-200.
Le QT, Fu KK, Kaplan MJ, Terris DJ, Fee WE, Goffinet DR. Lymph node metastasis in maxillary sinus carcinoma. Int J Radiat Oncol Biol Phys 2000;46:541-549.
Ogawa K, Toita T, Kakinohana Y, et al. Postoperative radiotherapy for squamous cell carcinoma of the maxillary sinus: analysis of local control and late complications. Oncol Rep 2001;8:315-319.
Ferrari M, Ioppi A, Schreiber A, et al. Malignant tumors of the maxillary sinus: prognostic impact of neurovascular invasion in a series of 138 patients. Oral Oncol 2020;106:104672.
Maroldi R, Ravanelli M, Borghesi A, Farina D. Paranasal sinus imaging. Eur J Radiol 2008;66:372-386.
Lee DJ, Lee MJ, Kwon KH, Chung EJ, Yoon DY, Rho YS. Discrepancy between preoperative MRI evaluation and intraoperative or postoperative pathological findings for the extent of local invasion in maxillary squamous cell carcinoma. Int J Oral Maxillofac Surg 2014;43:674-679.
Kano S, Hayashi R, Homma A, et al. Effect of local extension sites on survival in locally advanced maxillary sinus cancer. Head Neck 2014;36:1567-1572.
Morris LG, Patel SG, Shah JP, Ganly I. High rates of regional failure in squamous cell carcinoma of the hard palate and maxillary alveolus. Head Neck 2011;33:824-830.